{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:05:53Z","timestamp":1778526353975,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00595-017-1602-y","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T23:26:01Z","timestamp":1508801161000},"page":"422-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma"],"prefix":"10.1007","volume":"48","author":[{"given":"Masahiro","family":"Yanagiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Nitadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Anraku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"1602_CR1","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:S260\u20135.","journal-title":"J Thorac Oncol"},{"key":"1602_CR2","first-page":"34","volume-title":"Tumors of the thymus. Atlas of tumor pathology","author":"J Rosai","year":"1976","unstructured":"Rosai J, Levine GD. Tumors of the thymus. Atlas of tumor pathology, 2nd series, fascicle 13. Washington, DC: Armed Forces Institute of Pathology. 1976. p. 34\u2013161."},{"key":"1602_CR3","first-page":"40","volume-title":"Tumors of the mediastinum. Atlas of tumor pathology","author":"Y Shimosato","year":"1997","unstructured":"Shimosato Y, Mukai K. Tumors of the mediastinum. Atlas of tumor pathology, 3rd series, fascicle 21. Washington, DC: Armed Forces Institute of Pathology, 1997. p. 40\u2013120."},{"key":"1602_CR4","doi-asserted-by":"crossref","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","volume":"6","author":"F Detterbeck","year":"2011","unstructured":"Detterbeck F, Youssef S, Ruffini E, Okumura M. A review of prognostic factors in thymic malignancies. J Thorac Oncol. 2011;6:S1698\u2013704.","journal-title":"J Thorac Oncol"},{"key":"1602_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ejcts\/ezt649","volume":"46","author":"E Ruffini","year":"2014","unstructured":"Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, et al. European Association of Thoracic Surgeons (ESTS) Thymic Working Group. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2014;46:361\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1602_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","volume":"94","author":"M Okumura","year":"2002","unstructured":"Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002;94:624\u201332.","journal-title":"Cancer"},{"key":"1602_CR7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","volume":"77","author":"K Kondo","year":"2004","unstructured":"Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77:1183\u20138.","journal-title":"Ann Thorac Surg"},{"key":"1602_CR8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejcts.2004.04.041","volume":"26","author":"F Rea","year":"2004","unstructured":"Rea F, Marulli G, Girardi R, Bortolotti L, Favaretto A, Galligioni A, et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg. 2004;26:412\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1602_CR9","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","volume":"21","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21:2807\u201315.","journal-title":"World J Gastroenterol"},{"key":"1602_CR10","first-page":"2731","volume":"8","author":"QT Zhao","year":"2015","unstructured":"Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, et al. Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients. Onco Targets Ther. 2015;8:2731\u20138.","journal-title":"Onco Targets Ther"},{"key":"1602_CR11","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/ijc.28536","volume":"134","author":"MX Li","year":"2014","unstructured":"Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134:2403\u201313.","journal-title":"Int J Cancer"},{"key":"1602_CR12","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1245\/s10434-014-3815-2","volume":"21","author":"G Malietzis","year":"2014","unstructured":"Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, Jenkins JT. The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21:3938\u201346.","journal-title":"Ann Surg Oncol"},{"key":"1602_CR13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2008.05.046","volume":"137","author":"KM Sarraf","year":"2009","unstructured":"Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil\/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:425\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1602_CR14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JTO.0000000000000399","volume":"10","author":"NA Cannon","year":"2015","unstructured":"Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol. 2015;10:280\u20135.","journal-title":"J Thorac Oncol"},{"key":"1602_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature"},{"key":"1602_CR16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/01635581.2001.9680613","volume":"41","author":"DC McMillan","year":"2001","unstructured":"McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer. 2001;41:64\u20139.","journal-title":"Nutr Cancer"},{"key":"1602_CR17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218\u201330.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1602_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF03218097","volume":"48","author":"T Murakawa","year":"2000","unstructured":"Murakawa T, Nakajima J, Kohno T, Tanaka M, Matsumoto J, Takeuchi E, et al. Results from surgical treatment for thymoma. 43\u00a0years of experience. Jpn J Thorac Cardiovasc Surg. 2000;48:89\u201395.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"1602_CR19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1097\/JTO.0b013e3181f13682","volume":"5","author":"J Huang","year":"2010","unstructured":"Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol. 2010;5:2017\u201323.","journal-title":"J Thorac Oncol"},{"key":"1602_CR20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"1602_CR21","doi-asserted-by":"publisher","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"J Budczies","year":"2012","unstructured":"Budczies J, Klauschen F, Sinn BV, Gy\u0151rffy B, Schmitt WD, Darb-Esfahani S, et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 2012;7:e51862. doi:\n                        10.1371\/journal.pone.0051862\n                        \n                    .","journal-title":"PLoS One"},{"key":"1602_CR22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073\u201381.","journal-title":"Carcinogenesis"},{"key":"1602_CR23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/JTO.0b013e3181da78f9","volume":"5","author":"C O\u2019Dowd","year":"2010","unstructured":"O\u2019Dowd C, McRae LA, McMillan DC, Kirk A, Milroy R. Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer. J Thorac Oncol. 2010;5:988\u201392.","journal-title":"J Thorac Oncol"},{"key":"1602_CR24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.amjsurg.2007.12.057","volume":"197","author":"RA Smith","year":"2009","unstructured":"Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466\u201372.","journal-title":"Am J Surg"},{"key":"1602_CR25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1245\/s10434-010-1383-7","volume":"18","author":"YK Vashist","year":"2011","unstructured":"Vashist YK, Loos J, Dedow J, Tachezy M, Uzunoglu G, Kutup A, et al. Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol. 2011;18:1130\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1602_CR26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjsurg.2015.03.022","volume":"210","author":"H Zhang","year":"2015","unstructured":"Zhang H, Xia H, Zhang L, Zhang B, Yue D, Wang C. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer. Am J Surg. 2015;210:526\u201335.","journal-title":"Am J Surg"},{"key":"1602_CR27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.athoracsur.2008.11.022","volume":"87","author":"RJ Korst","year":"2009","unstructured":"Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87:1641\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"7 Suppl 3","key":"1602_CR28","doi-asserted-by":"crossref","first-page":"S1743","DOI":"10.1097\/JTO.0b013e31821ea60c","volume":"6","author":"D Gomez","year":"2011","unstructured":"Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol. 2011;6(7 Suppl 3):S1743\u20138.","journal-title":"J Thorac Oncol"},{"key":"1602_CR29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.athoracsur.2015.06.034","volume":"101","author":"D Zhou","year":"2016","unstructured":"Zhou D, Deng XF, Liu QX, Zheng H, Min JX, Dai JG. The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: a meta-analysis. Ann Thorac Surg. 2016;101:305\u201310.","journal-title":"Ann Thorac Surg"},{"key":"1602_CR30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182598a91","volume":"7","author":"MK Bae","year":"2012","unstructured":"Bae MK, Byun CS, Lee CY, Lee JG, Park IK, Kim DJ, et al. Clinical outcomes and prognosis of recurrent thymoma management. J Thorac Oncol. 2012;7:1304\u201314.","journal-title":"J Thorac Oncol"},{"key":"1602_CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4993\/acrt.19.54","volume":"19","author":"M Tomita","year":"2011","unstructured":"Tomita M, Shimizu T, Ayabe T, Onitsuka T. Persistently high neutrophil to lymphocyte ratio after surgery indicate poor prognosis in non-small cell lung cancer patients. Ann Cancer Res Ther. 2011;19:54\u20136.","journal-title":"Ann Cancer Res Ther"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-017-1602-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-017-1602-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-017-1602-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T17:09:08Z","timestamp":1520615348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-017-1602-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1602"],"URL":"https:\/\/doi.org\/10.1007\/s00595-017-1602-y","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}